January/February #161 : Cancer Cutters?

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Fighting AIDS With Lessons Learned From Black History

Adoption Issues

No Child Left Behind

Hard Return

Female Condom

Medicine Chest

Cancer Cutters?

Cuppa Joe

Treatment: By Design

Green Goddess

Resolution Revolution

Flying United

Precious Little

POZ Picks-Winter Reads

You Said It- January/February 2010

Rubber Soul

The Best of the POZ Blogs-January/February 2010

Editor's Letter-January/February 2010

Your Feedback-January/February 2010

In Memoriam

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

Scroll down to comment on this story.

email print

January / February 2010

Cancer Cutters?

Along with other healthy habits, keeping your CD4 count high might help protect against cancer. Reviewing records of 52,278 HIV-positive people from 1998 to 2006, French researchers concluded that those with CD4 counts of 500 or more were less likely to develop any of the seven cancers most common among people with HIV. Those seven, in order of frequency:
  • Kaposi’s sarcoma
  • Non-Hodgkin’s lymphoma  (NHL)
  • Lung cancer
  • Hodgkin’s lymphoma
  • Liver cancer
  • Anal cancer
  • Cervical cancer
For anal cancer, higher risk was linked to two things: having had HIV for many years and having had, at some point, a CD4 count under 200 (and viral load above 100,000) for two years or more. For the other cancers, current 
CD4 count seemed to make the difference. The researchers recommended screening HIV-positive people for these cancers—especially if CD4 counts are low. This research may further support arguments for raising the CD4 level at which HIV treatment should begin from the current recommendation of 350 to 500.

Search: cancer, risk, Kaposi's sarcoma, non-Hodgkin's lymphoma, lung cancer, Hodgkin's lymphoma, liver cancer, anal cancer, cervical cancer

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.